Vedolizumab May Not Worsen COVID-19 Outcomes in IBD Patients Vedolizumab May Not Worsen COVID-19 Outcomes in IBD Patients

Vedolizumab does not appear to worsen COVID-19 outcomes in patients with IBD, according to data from the Surveillance of Coronavirus Under Research Exclusion for IBD (SECURE-IBD) registry.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Gastroenterology News Source Type: news